From Research to Reality: Crafting an Image of the Current State of Psychedelic-Assisted Psychotherapies for Substance Use Disorders.

Psychedelic-assisted psychotherapies for substance use disorders are transitioning from experimental research into clinical practice. This paper reviews the current evidence, highlighting promising results for treating alcohol and opioid use disorders with psilocybin and ibogaine, respectively, while noting methodological limitations and the need for larger controlled trials. It discusses challenges in integrating these therapies into existing healthcare systems, including regulatory hurdles, therapist training, and ensuring equitable access. The authors argue that careful implementation and continued research are necessary to translate findings into effective, real-world treatments.

Study at a glance

Abstract

From Research to Reality: Crafting an Image of the Current State of Psychedelic-Assisted Psychotherapies for Substance Use Disorders.